ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02770170
Recruitment Status : Recruiting
First Posted : May 12, 2016
Last Update Posted : October 17, 2018
Sponsor:
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 30, 2019
  Estimated Study Completion Date : August 31, 2020